Poland· PL-100006028
Antidral
A other cicatrizants product containing aluminii chloridum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Aluminii chloridum is registered in 5 of 19 countries.
Countries holding a registration under ATC D03AX (other cicatrizants), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Aluminii chloridum · ATC D03AX
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Aluminii chloridum
- Manufacturer
- Teva Pharmaceuticals Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D03AX
- ATC class
- Other cicatrizants
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990126118
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aluminii chloridum in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAluminaHahnemann Laboratories, INC.
- United KingdomActonorm gelWallace Manufacturing Chemists Ltd
- BelgiumAlumina Boiron 15CHBoiron
- FinlandAlumina
- NetherlandsAluminaHeel Belgium n.v.
- GermanyGargarisma Zum GurgelnHermes Arzneimittel Gmbh
- IrelandAnhydrol Forte 20% w/v Cutaneous SolutionDermal Laboratories (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Gargarisma Zum Gurgeln, Mallebrin
- United Kingdom (Northern Ireland) · Anhydrol Forte
- Hungary · Solutio Antisudorica Fono Viii.
- Ireland · Anhydrol Forte
- Portugal · Almigástrico, Pepsamar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e5e7305-4e5a-4add-b3a1-530cedc5f957 GET /v1/drugs/0e5e7305-4e5a-4add-b3a1-530cedc5f957?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn na skórę",
"source": "urpl",
"strength": "100 mg/g",
"packaging": "OTC ¦ Skasowane ¦ 906\n1 op. 30 ml\n05909990126118 ¦ OTC ¦ 907\n1 butelka 50 ml",
"substance": "Aluminii chloridum 100 mg/1 g",
"common_name": "Aluminii chloridum",
"pl_product_id": "100006028",
"pozwolenie_nr": "01261",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about aluminii chloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.